Pinnacle Food Group Achieves Milestone in Recombinant Human Lactoferrin Production
Pinnacle Food Group Limited has successfully developed a recombinant yeast strain for producing human lactoferrin using a methanol-free fermentation method. This advancement reduces operational costs and fire hazards, crucial for applications in infant nutrition and pharmaceuticals.
Theia Market Signal Identification - AI Assisted
Pinnacle Food Group Limited has developed a recombinant yeast strain for human lactoferrin (rhLF) production utilizing a patented methanol-free fermentation method. This innovation eliminates the need for methanol, addressing safety concerns and reducing operational costs significantly.
The technology has been validated for other protein targets at pilot scale, indicating readiness for commercial manufacturing. This milestone supports Pinnacle's aim to establish itself as a leading B2B manufacturer of high-value biological ingredients, enhancing its competitiveness in the market. The successful application of this fermentation method may influence industry standards for safety and efficiency in biomanufacturing.
Comments